Metastatic Thyroid Gland Oncocytic Carcinoma
2 clinical trials · Condition
◉ Watch Metastatic Thyroid Gland Oncocytic Carcinoma
| Record | Firm | Date |
|---|---|---|
| XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer (NCT06959641) | Jochen Lorch | 2025-06-06 |
| Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer (NCT05453799) | Northwestern University | 2022-07-21 |
Track Metastatic Thyroid Gland Oncocytic Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.